|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross Profit | |||||
| Operating Expenses: | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Restructuring costs | |||||
| Total Operating Expenses | |||||
| Loss from Operations | |||||
| Other Income (Expense): | |||||
| Interest and other income | |||||
| Interest expense | |||||
| Interest and other expense | |||||
| Amortization of debt discount | |||||
| Gain (loss) on foreign currency transactions | |||||
| Gain on lease termination | |||||
| Gain (loss) on disposal of property and equipment | |||||
| Loss on assets held for sale | |||||
| Total Other Expense | |||||
| Loss Before Income Taxes | |||||
| Income tax benefit | |||||
| Net Loss | |||||
| Net Loss attributable to noncontrolling interest | |||||
| Net Loss attributable to LiqTech International, Inc. | |||||
| Loss Per Common Share – Basic and Diluted (in dollars per share) | |||||
| Weighted-Average Common Shares Outstanding – Basic and Diluted (in shares) | |||||
Loading...